Patterson Companies Reports 6% Comparable Revenue Growth in First Quarter

$0.45 EPS on Comparable Basis

ST. PAUL, Minn.--()--Patterson Companies, Inc. (Nasdaq: PDCO) today reported consolidated sales of $847,422,000 for the first quarter of fiscal 2012 ended July 30, an increase of approximately 6% on a comparable basis from the year-earlier period. Comparable basis sales exclude the impact of an extra week in the first quarter of fiscal 2011. Reported sales in last year’s first quarter totaled $849,787,000.

Patterson reported first quarter net income of $48,610,000 or $0.42 per diluted share, which included previously-announced non-cash expense of $0.03 per diluted share related to Patterson’s Employee Stock Ownership Plan (ESOP). After adjusting for this ESOP-related expense, first quarter earnings were $0.45 per diluted share. Patterson reported earnings of $53,925,000 or $0.45 per diluted share in the first quarter of fiscal 2011. As reported in Patterson’s earnings release for the fourth quarter of fiscal 2011, the non-cash ESOP expense will affect the ongoing comparability of results for fiscal year 2012 earnings and beyond when compared to periods ended before fiscal 2012. The total impact in fiscal 2012 is estimated at $0.12 per share. A reconciliation of the impact on net earnings and per share amounts from this change is included at the end of this release.

In other developments, Webster Veterinary, Patterson’s companion-pet veterinary business, today announced the acquisition of American Veterinary Supply Corporation (AVSC), a full-service veterinary distributor on Long Island that serves approximately 2,000 veterinary practices and hospitals in the New York metropolitan area. With sales of approximately $25 million and 14 field sales representatives, AVSC will be operated as Webster’s eighteenth branch. Terms of the transaction were not disclosed.

Patterson Dental, Patterson’s largest business, reported comparable basis sales growth of approximately 4% to $533,367,000 in the first quarter.

  • Sales of consumable dental supplies and printed office products increased an estimated 2% on a comparable basis in the first quarter.
  • Sales of dental equipment and software increased an estimated 7% on a comparable basis from the year-earlier level, paced by strong, double-digit sales growth of new-technology equipment, including CEREC® and digital radiography products.
  • Sales of other services and products, consisting primarily of technical service, parts and labor, software support services and artificial teeth, increased an estimated 6% on a comparable basis from last year’s first quarter.

First quarter sales of Patterson Medical, the rehabilitation supply and equipment unit, rose approximately 12% on a comparable basis to $134,452,000. Internally-generated sales increased approximately 1% on a comparable basis, while the June 2010 acquisitions of the healthcare businesses of DCC Healthcare and favorable foreign currency adjustments accounted for the balance of the year-over-year sales growth. Sales of the Webster Veterinary unit increased approximately 8% on a comparable basis from the year-earlier period to $179,603,000.

Scott P. Anderson, president and chief executive officer, commented: “Within Patterson Dental, sales of consumable supplies grew modestly on a comparable basis, as the market continues to be affected by a sluggish economy. Our dental equipment growth was driven by strong sales of our various new-technology equipment lines as dentists are continuing to invest in the digital conversion that is transforming the practice of dentistry. Patterson Dental is the leading distributor of new-technology equipment by a significant margin, and we see ongoing growth opportunities in this key area.”

He continued: “We believe Patterson Medical continued to gain market share in the first quarter despite market and changing regulatory conditions in North America and overseas. The integration of the DCC businesses has been completed, and no significant incremental expenses related to this transaction are anticipated going forward. We continue to believe Patterson Medical is well positioned, domestically and internationally, as an ongoing growth driver of our overall performance.”

Anderson added: “Webster’s first quarter sales growth on a comparable basis, which was driven by improved sales of both consumable supplies and equipment and software, was largely consistent with our internal forecast. We plan to continue investing in the unit’s relatively new equipment and service business, which has expanded Webster’s full-service platform. Webster also is investing in a range of technology initiatives aimed at strengthening the profitability of veterinary practices and forging stronger relationships between pet owners and their veterinarians. We believe these initiatives should further strengthen Webster’s competitive position in coming years.”

Patterson has used internally-generated cash to repurchase $157 million or 4.9 million shares of its common stock since its new 25 million share, five-year buyback was authorized in March 2011. This included the repurchase of nearly 2 million shares in the most recent quarter.

Patterson reiterated its previously announced financial guidance of $1.90 to $2.00 per diluted share for fiscal 2012.

 
 
ESOP Expense Reconciliation Table        
Dollars in thousands, except EPS
July 30, 2011 July 31, 2010
Net Income $ 48,610 $ 53,925
Incremental ESOP Expense     3,219       -
Adjusted Net Income (non-GAAP)   $ 51,829     $ 53,925
Diluted Earnings Per Share $ 0.42 $ 0.45
Incremental ESOP Expense   $ 0.03       -
Adjusted Earnings Per Share (non-GAAP)   $ 0.45     $ 0.45
 
 

About Patterson Companies, Inc.
Patterson Companies, Inc. is a value-added distributor serving the dental, companion-pet veterinarian and rehabilitation supply markets.
Dental Market
As Patterson’s largest business, Patterson Dental provides a virtually complete range of consumable dental products, equipment and software, turnkey digital solutions and value-added services to dentists and dental laboratories throughout North America.
Veterinary Market
Webster Veterinary is the nation’s second largest distributor of consumable veterinary supplies, equipment and software, diagnostic products, vaccines and pharmaceuticals to companion-pet veterinary clinics.
Rehabilitation Market
Patterson Medical is the world’s leading distributor of rehabilitation supplies and non-wheelchair assistive patient products to the physical and occupational therapy markets. The unit’s global customer base includes hospitals, long-term care facilities, clinics and dealers.

This release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements are information of a non-historical nature and are subject to risks and uncertainties that are beyond the Company’s ability to control. The Company cautions shareholders and prospective investors that the following factors, among others, may cause actual results to differ materially from those indicated by the forward-looking statements: competition within the dental, veterinary, and rehabilitative and assistive living supply industries; changes in the economics of dentistry, including reduced growth in expenditures by private dental insurance plans, the effects of economic conditions and the effects of healthcare reform, which may affect future per capita expenditures for dental services and the ability and willingness of dentists to invest in high-technology products; the effects of healthcare related legislation and regulation which may affect expenditures or reimbursements for rehabilitative and assistive products; changes in the economics of the veterinary supply market, including reduced growth in per capita expenditures for veterinary services and reduced growth in the number of households owning pets; the ability of the Company to maintain satisfactory relationships with its sales force; unexpected loss of key senior management personnel; unforeseen operating risks; risks associated with the dependence on manufacturers of the Company’s products; and the ability of the Company to successfully integrate the recent acquisitions into its existing business. Forward-looking statements are qualified in their entirety by the cautionary language set forth in the Company's filings with the Securities and Exchange Commission.

 

First Quarter Conference Call and Replay

Patterson’s first quarter earnings conference call will start at 10:00 a.m. Eastern today. Investors can listen to a live webcast of the conference call at www.pattersoncompanies.com. The conference call will be archived on Patterson’s web site. A replay of the first quarter conference call can be heard for one month at 1-303-590-3030 and providing the conference ID: 4465229.

 
 
 
PATTERSON COMPANIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except for per share amounts)
(Unaudited)
       
 
Three Months Ended
 
July 30, July 31,
2011 2010
 
 
Net sales $ 847,422 $ 849,787
 
Gross profit 278,276 280,200
 
Operating expenses   196,283     191,176  
 
Operating income 81,993 89,024
 
Other expense, net   (5,135 )   (3,257 )
 
Income before taxes 76,858 85,767
 
Income taxes   28,248     31,842  
 
Net income $ 48,610   $ 53,925  
 
 
Earnings per share:
Basic $ 0.42 $ 0.45
Diluted $ 0.42 $ 0.45
 
Shares:
Basic 115,576 119,022
Diluted 116,285 119,784
 
Dividends declared per common share $ 0.12 $ 0.10
 
Gross margin 32.8 % 33.0 %
 
Operating expenses as a % of net sales 23.2 % 22.5 %
 
Operating income as a % of net sales 9.7 % 10.5 %
 
Effective tax rate 36.8 % 37.1 %
 
 
 
PATTERSON COMPANIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in thousands)
       
 
July 30, April 30,
2011 2011
(Unaudited)
ASSETS
Current assets:
Cash and short-term investments $ 373,776 $ 388,665
Receivables, net 423,285 465,170
Inventory 346,476 336,094
Prepaid expenses and other current assets   35,195   40,780
Total current assets 1,178,732 1,230,709
 
Property and equipment, net 196,243 189,583
Goodwill and other intangible assets 1,018,983 1,022,832
Investments and other   123,555   121,844
 
Total Assets $ 2,517,513 $ 2,564,968
 
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable $ 201,801 $ 210,033
Other accrued liabilities 147,909 157,398
Current maturities of long-term debt   -   -
Total current liabilities 349,710 367,431
 
Long-term debt 525,000 525,000
Other non-current liabilities   108,652   111,997
Total liabilities 983,362 1,004,428
 
Stockholders' equity   1,534,151   1,560,540
 
Total Liabilities and Stockholders' Equity $ 2,517,513 $ 2,564,968
 
 
 

PATTERSON COMPANIES, INC.

SUPPLEMENTARY FINANCIAL DATA
(Dollars in thousands)
(Unaudited)
       
 
 
Three Months Ended
July 30, July 31,
2011 2010
 
Consolidated Net Sales
Consumable and printed products $ 574,962 $ 586,603
Equipment and software 199,651 192,221
Other   72,809     70,963  
Total $ 847,422   $ 849,787  
 
Dental Supply
Consumable and printed products $ 308,869 $ 325,992
Equipment and software 161,027 154,571
Other   63,471     62,115  
Total $ 533,367   $ 542,678  
 
Rehabilitation Supply
Consumable and printed products $ 96,716 $ 90,925
Equipment and software 31,057 30,376
Other   6,679     6,173  
Total $ 134,452   $ 127,474  
 
Veterinary Supply
Consumable and printed products $ 169,377 $ 169,686
Equipment and software 7,567 7,274
Other   2,659     2,675  
Total $ 179,603   $ 179,635  
 
Other (Expense) Income, net
Interest income $ 1,829 $ 2,643
Interest expense (6,353 ) (6,890 )
Other   (611 )   990  
$ (5,135 ) $ (3,257 )
 
 
 
PATTERSON COMPANIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Dollars in thousands)
(Unaudited)
       
Three Months Ended
July 30, July 31,
2011 2010
 
 
Operating activities:

Net income

$ 48,610 $ 53,925
Depreciation & amortization 9,082 9,523
Stock-based compensation 3,180 2,669
ESOP compensation 5,700 525
Change in assets and liabilities, net of acquired   144     (43,884 )
Net cash provided by operating activities 66,716 22,758
 
Investing activities:
Additions to property and equipment, net of disposals (10,247 ) (9,130 )
Acquisitions and equity investments   -     (46,682 )
Net cash used in investing activities (10,247 ) (55,812 )
 
Financing activities:
Dividends paid (13,801 ) (11,916 )
Share repurchases (59,913 ) -
Other financing activities   4,199     7,988  
Net cash used in financing activities (69,515 ) (3,928 )
 
Effect of exchange rate changes on cash   (1,843 )   (5,182 )
 
 
Net decrease in cash and cash equivalents $ (14,889 ) $ (42,164 )
 
 

Contacts

Patterson Companies, Inc.
R. Stephen Armstrong, 651-686-1600
Executive Vice President & CFO
or
Equity Market Partners
Richard G. Cinquina, 904-415-1415

Recent Stories from Patterson Companies, Inc.

RSS feed for Patterson Companies, Inc.